Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Cancers|November 28, 2013
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancerCatherine Oakman, Marta Pestrin, Silvia Bessi, et al.
Ecancermedicalscience|April 17, 2013
Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?Giuseppe Curigliano, Carmen Criscitiello, Fabrice Andrè, et al.
Critical Reviews in Oncology/Hematology|February 24, 2007
Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?Laura Biganzoli, Wederson M Claudino, Marta Pestrin, et al.
BMC Medicine|April 11, 2015
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancersIlenia Migliaccio, Luca Malorni, Christopher D Hart, et al.
Breast (Edinburgh, Scotland)|September 1, 2015
Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypesChristopher D Hart, Giuseppina Sanna, Olimpia Siclari, et al.
Breast (Edinburgh, Scotland)|August 28, 2007
Using specific cytotoxics with a targeted mindAngelo Di Leo, Wederson M Claudino, Marta Pestrin, et al.
Cancers|December 5, 2019
The Emerging Role of <i>ESR1</i> Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine TherapyIrene De Santo, Amelia McCartney, Ilenia Migliaccio, et al.
Dermatology Online Journal|April 28, 2006
Generalized B-cell non Hodgkin's lymphoma in association with leukocytoclastic vasculitis and disseminated intravascular coagulationCarla Cardinali, Simone Santini, Angelo di Leo, et al.
Breast Cancer Research : BCR|May 14, 2009
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancerCatherine Oakman, Silvia Bessi, Elena Zafarana, et al.
NPJ Breast Cancer|July 20, 2017
A multifactorial 'Consensus Signature' by <i>in silico</i> analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancerNatalie Turner, Mattia Forcato, Simona Nuzzo, et al.
Pageof 18